1. "1994"
Formats
  1. Journal Article (1065)
  2. Meeting Abstract (359)
  3. Conference Paper (95)
  4. Book Section (24)
  5. Book Whole (5)
Groups
  1. Sloan Kettering Institute Faculty (361)
  2. Department of Medicine (296)
  3. GSK Faculty (257)
  4. Molecular Pharmacology and Chemistry Program Faculty (194)
  5. Surgery (171)
  6. Solid Tumor Oncology Division (160)

More Groups

People
  1. Carlos Cordon-Cardo (44)
  2. Raju Chaganti (39)
  3. William Fair (38)
  4. Steven Larson (37)
  5. Zvi Fuks (36)
  6. George Bosl (35)

More People

Years
  1. 1994 (1548)
Publications
  1. Blood (76)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (72)
  3. Cancer (48)
  4. Journal of Cellular Biochemistry (46)
  5. Journal of Biological Chemistry (36)
  6. International Journal of Radiation Oncology, Biology, Physics (34)

More Publications

Publishers
  1. Elsevier Inc. (141)
  2. American Association for Cancer Research (106)
  3. Elsevier Science, Inc. (91)
  4. Wiley Blackwell (82)
  5. Lippincott Williams & Wilkins (77)
  6. American Society of Hematology (76)

More Publishers

Results (1548)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reduced natural killer cell activity in women at familial risk for breast cancer
    Meeting Abstract

    Bovbjerg, D.; Valdimarsdottir, H.; Borgen, P.; Holland, J.; Osborne, M.; Lubin, M.
    FASEB Journal (1994)

    Fulltext@MSK | Save
  • TCR induced recruitment of p56(lck) via its SH2,3 domain to MAPK and the zeta chain of the TCR
    Meeting Abstract

    August, A.; Dupont, B.
    FASEB Journal (1994)

    Fulltext@MSK | Save
  • Effect of pH on the kinetic parameters of vaccinia DNA topoisomerase I (Topo I)
    Meeting Abstract

    Stivers, J. T.; Shuman, S.; Mildvan, A. S.
    FASEB Journal (1994)

    Fulltext@MSK | Save
  • The pathway of chaperone-mediated protein folding
    Meeting Abstract

    Hartl, F. U.
    FASEB Journal (1994)

    Fulltext@MSK | Save
  • Multiorgan system failure syndrome in patients undergoing myeloablative chemotherapy and autologous bone marrow rescue for malignant brain tumors
    Meeting Abstract

    George, D.; Ginsberg, J.; Weingast, R.; Papadakis, V.; Gillio, A. P.; Papadopoulos, E.; Heller, G.; Finlay, J. L.
    Experimental Hematology (1994)

    Fulltext@MSK | Save
  • Deficient clonogenic capacity of selected CD34+ progenitors in patients with aplastic anemia (AA) and hypocellular myelodysplastic syndrome (MDS): Further evidence of intrinsic stem cell defects in these disorders
    Meeting Abstract

    Childs, B.; Tomelden, C.; O'Reilly, R. J.; Castro-Malaspina, H.
    Experimental Hematology (1994)

    Fulltext@MSK | Save
  • Antibody mediated receptor dimerization and downregulation enhance inhibition of A431 cell growth by anti-epidermal growth factor receptor monoclonal antibody
    Meeting Abstract

    Mendelsohn, J.; Fan, Z.; Lu, Y.
    Clinical Research (1994)

    Fulltext@MSK | Save
  • Anti-Hu antibody (Ab) paraneoplastic syndrome (PNS) in pediatric neuroblastoma (NB): Response to immunomodulation
    Meeting Abstract

    Wayne, A. S.; Grahna, N.; Casadonte, J.; Geller, D.; Dalmau, J. O.
    Blood (1994)

    Fulltext@MSK | Save
  • An indirect platelet count using a platelet-specific monoclonal antibody and flow cytometry can produce reliable platelet counts for assessing thrombocytopenias
    Meeting Abstract

    Groner, W.; Mayer, K.; Chapman, E. S.
    Blood (1994)

    Fulltext@MSK | Save
  • Design and prospective implementation of population pharmacokinetic studies during the development of docetaxel (D) (RP 56976): A new anticancer drug
    Meeting Abstract

    Bruno, R.; Dorr, M. B.; Montay, G.; Frydman, A.; This, F.; Fumoleau, P.; Kay, S.; Kavanagh, G. H.; Burris, H. A.; Rigas, J. R.; more...
    Clinical Pharmacology & Therapeutics (1994)

    Fulltext@MSK | Save